145 related articles for article (PubMed ID: 38478337)
1. ALDH Activity Assay: A Method for Cancer Stem Cell (CSC) Identification and Isolation.
Del Vecchio V; La Noce M; Tirino V
Methods Mol Biol; 2024; 2777():83-89. PubMed ID: 38478337
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and Isolation of Cancer Stem Cells Using ALDH Activity Assay.
Mele L; Liccardo D; Tirino V
Methods Mol Biol; 2018; 1692():43-48. PubMed ID: 28986885
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer stem cells are enriched in side population and aldehyde dehydrogenase bright overlapping population.
Yasuda K; Torigoe T; Morita R; Kuroda T; Takahashi A; Matsuzaki J; Kochin V; Asanuma H; Hasegawa T; Saito T; Hirohashi Y; Sato N
PLoS One; 2013; 8(8):e68187. PubMed ID: 23967051
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ
Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635
[TBL] [Abstract][Full Text] [Related]
5. Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay.
Zhou L; Sheng D; Wang D; Ma W; Deng Q; Deng L; Liu S
Cell Biol Toxicol; 2019 Apr; 35(2):161-177. PubMed ID: 30220009
[TBL] [Abstract][Full Text] [Related]
6. ALDEFLUOR activity, ALDH isoforms, and their clinical significance in cancers.
Duan JJ; Cai J; Gao L; Yu SC
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2166035. PubMed ID: 36651035
[TBL] [Abstract][Full Text] [Related]
7. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
Kim D; Choi BH; Ryoo IG; Kwak MK
Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
[TBL] [Abstract][Full Text] [Related]
8. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry-based assay.
Moreb JS; Zucali JR; Ostmark B; Benson NA
Cytometry B Clin Cytom; 2007 Jul; 72(4):281-9. PubMed ID: 17111384
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase activity is a cancer stem cell marker of tongue squamous cell carcinoma.
Zou B; Sun S; Qi X; Ji P
Mol Med Rep; 2012 Apr; 5(4):1116-20. PubMed ID: 22307065
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer stem cells: mechanobiology reveals highly invasive cancer cell subpopulations.
Alvarez-Elizondo MB; Weihs D
Cell Mol Life Sci; 2022 Feb; 79(3):134. PubMed ID: 35171381
[TBL] [Abstract][Full Text] [Related]
12. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
[TBL] [Abstract][Full Text] [Related]
13. Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors.
Gaur P; Sceusi EL; Samuel S; Xia L; Fan F; Zhou Y; Lu J; Tozzi F; Lopez-Berestein G; Vivas-Mejia P; Rashid A; Fleming JB; Abdalla EK; Curley SA; Vauthey JN; Sood AK; Yao JC; Ellis LM
Gastroenterology; 2011 Nov; 141(5):1728-37. PubMed ID: 21806944
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of drugs targeting cancer stem cell (CSC) and non-CSC populations on lung primary tumors and metastasis.
Larzabal L; El-Nikhely N; Redrado M; Seeger W; Savai R; Calvo A
PLoS One; 2013; 8(11):e79798. PubMed ID: 24278179
[TBL] [Abstract][Full Text] [Related]
15. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase.
Clay MR; Tabor M; Owen JH; Carey TE; Bradford CR; Wolf GT; Wicha MS; Prince ME
Head Neck; 2010 Sep; 32(9):1195-201. PubMed ID: 20073073
[TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
Ma S; Chan KW; Lee TK; Tang KH; Wo JY; Zheng BJ; Guan XY
Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979
[TBL] [Abstract][Full Text] [Related]
17. Isolation of cancer stem cells from cultured breast cancer cells and xenografted breast tumors based on aldehyde dehydrogenase activity.
Fernando W; Rowter D; Arun RP; Venkatesh J; Marcato P
Methods Cell Biol; 2022; 171():111-125. PubMed ID: 35953196
[TBL] [Abstract][Full Text] [Related]
18. Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells.
Lin JJ; Huang CS; Yu J; Liao GS; Lien HC; Hung JT; Lin RJ; Chou FP; Yeh KT; Yu AL
Breast Cancer Res; 2014 Mar; 16(2):R29. PubMed ID: 24670249
[TBL] [Abstract][Full Text] [Related]
19. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
Wang L; Park P; La Marca F; Than KD; Lin CY
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
[TBL] [Abstract][Full Text] [Related]
20. ALDH as a Stem Cell Marker in Solid Tumors.
Toledo-Guzmán ME; Hernández MI; Gómez-Gallegos ÁA; Ortiz-Sánchez E
Curr Stem Cell Res Ther; 2019; 14(5):375-388. PubMed ID: 30095061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
